Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1978 Mar;90(3):675–687.

Tumor induction in host-versus-graft disease. I. Clinical and pathologic features.

E A Cornelius
PMCID: PMC2018247  PMID: 24343

Abstract

Perinatal C57BL/1 mice given injections of (SJL/J X C57BL/1)F1 spleen cells developed a highly lethal runting syndrome, designated host-versus-graft disease (HVGD). The mortality was related to the dosage of F1 cells. Acute pathologic changes resembled those occurring in parent leads to F1 graft-versus-host disease (GVHD), except for more pronounced plasmacytosis. Mice suffering from HVGD recovered clinically with no sequelae except for a slight increase in the incidence of lymphomas over control mice. Such mice were hyperreactive to F1 cells utilized to initiate the original HVGD syndrome. Most of the tumors developed in those animals receiving the initial injection of F1 spleen cells within 24 hours of birth. Tumor incidence was unrelated to the clinical severity of HVGD. By contrast, GVHD in the same strain combination resulted in a much higher incidence of lymphomas in a much shorter time. Parental strain cells were detectable in the F1 hosts up to the time of tumor development. HVGD has a low tumor induction potential; GVHD has a high tumor induction potential.

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. Y., Gleichmann E., Gleichmann H., Beldotti L., Andre-Schwartz J., Schwartz R. S. Chronic allogeneic disease. II. Development of lymphomas. J Exp Med. 1970 Sep 1;132(3):417–439. doi: 10.1084/jem.132.3.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cornelius E. A. Development of tumors as a result of graft-versus-host reaction. Exp Hematol. 1973;1(3):135–149. [PubMed] [Google Scholar]
  3. Cornelius E. A. Induction of both host- and donor-type tumors as a result of the graft-versus-host reaction. Transplantation. 1972 Jun;13(6):589–591. doi: 10.1097/00007890-197206000-00006. [DOI] [PubMed] [Google Scholar]
  4. Cornelius E. A. Induction of tumors and autoimmune changes in thymectomized mice. Am J Roentgenol Radium Ther Nucl Med. 1972 Apr;114(4):784–791. doi: 10.2214/ajr.114.4.784. [DOI] [PubMed] [Google Scholar]
  5. Cornelius E. A. Rapid viral induction of murine lymphomas in the graft-versus-host reaction. J Exp Med. 1972 Dec 1;136(6):1533–1544. doi: 10.1084/jem.136.6.1533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cornelius E. A. Sex-linked attenuation of the graft-versus-host reaction: effect on pathologic features, including tumor induction. J Natl Cancer Inst. 1974 Sep;53(3):759–762. doi: 10.1093/jnci/53.3.759. [DOI] [PubMed] [Google Scholar]
  7. Datta S. K., Schwartz R. S. Autoimmunization and graft versus host reactions. Transplant Rev. 1976;31:44–78. doi: 10.1111/j.1600-065x.1976.tb01452.x. [DOI] [PubMed] [Google Scholar]
  8. Gleichmann E., Gleichmann H., Wilke W. Autoimmunization and lymphomagenesis in parent to F1 combinations differing at the major histocompatibility complex: model for spontaneous disease caused by altered self-antigens? Transplant Rev. 1976;31:156–224. doi: 10.1111/j.1600-065x.1976.tb01454.x. [DOI] [PubMed] [Google Scholar]
  9. Grebe S. C., Streilein J. W. Graft-versus-Host reactions: a review. Adv Immunol. 1976;22:119–221. doi: 10.1016/s0065-2776(08)60549-0. [DOI] [PubMed] [Google Scholar]
  10. Grundmann E., Hobik H. P. Lymphoreticuläre Sarkome bei immunologisch geschädigten Mäusen. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1973 Jun 19;79(4):298–303. doi: 10.1007/BF00304023. [DOI] [PubMed] [Google Scholar]
  11. Hard R. C., Jr Correlation of immunological function with splenic histopathology during the preclinical stages of host-versus-graft syndrome in parent-F1 mouse chimeral. Transplantation. 1974 Jun;17(6):613–623. doi: 10.1097/00007890-197406000-00011. [DOI] [PubMed] [Google Scholar]
  12. Hard R. C., Jr Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells. Clin Exp Immunol. 1975 Nov;22(2):330–340. [PMC free article] [PubMed] [Google Scholar]
  13. Hard R. C., Jr, Kullgren B. Etiology, pathogenesis, and prevention of a fatal host-versus-graft syndrome in parent-F1 mouse chimeras. Am J Pathol. 1970 May;59(2):203–224. [PMC free article] [PubMed] [Google Scholar]
  14. Nakić B., Mikuska J., Kastelan A., Springer O., Silobrcić V. Quantitative analysis of the chimeric state in mice. IV. Cytological examination of mice rendered tolerant by neonatal inoculation of F1 hybrid spleen cells. Immunology. 1970 Jan;18(1):119–129. [PMC free article] [PubMed] [Google Scholar]
  15. SIMONSEN M. Graft versus host reactions. Their natural history, and applicability as tools of research. Prog Allergy. 1962;6:349–467. [PubMed] [Google Scholar]
  16. Schwartz R. S., Beldotti L. Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder. Science. 1965 Sep 24;149(3691):1511–1514. doi: 10.1126/science.149.3691.1511. [DOI] [PubMed] [Google Scholar]
  17. Simpson E., O'Hopp S., Harrison M., Mosier D., Melief K., Cantor H. Immunological disease induced by injecting F1 lymphoid cells into certain parental strains. Immunology. 1974 Dec;27(6):989–1007. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES